Handelsbanken Fonder AB Has $133.49 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Handelsbanken Fonder AB lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 255,743 shares of the medical equipment provider’s stock after purchasing an additional 63,201 shares during the quarter. Handelsbanken Fonder AB owned 0.07% of Intuitive Surgical worth $133,488,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the business. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $36,000. Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. Finally, DT Investment Partners LLC boosted its holdings in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.3 %

ISRG stock opened at $608.48 on Thursday. The company has a market cap of $216.73 billion, a PE ratio of 94.93, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The business has a 50-day simple moving average of $563.17 and a 200 day simple moving average of $522.88.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on ISRG. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Truist Financial lifted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.